Seeking Alpha

Econovan

Econovan
Send Message
View as an RSS Feed
View Econovan's Comments BY TICKER:
Latest  |  Highest rated
  • Finger Lickin' Value Down At Sanderson Farms [View article]
    Thanks James Sands, so I guess the article assuming fair value based on current earnings is flawed and also the 100% rating on predictability of earnings is flawed, since 10% growth is not a credible forecast except maybe over a very long time range.

    BTW, that Stub hub ad is really chewing up my little laptop,please makeit stop , thesetypeos arresul t of keyboarderrors duetothestubhub ad.
    Mar 31, 2015. 12:55 PM | Likes Like |Link to Comment
  • Is GE A Top-Notch Income Stock? [View article]
    I don't see mentioned in articles about GE that its exposure to energy is not just GE Oil&Gas, but also its many businesses related to demand for alternative and renewable energy, which is negatively affected by low oil and gas prices. Does the business hedge for this? I started thinking about this when I saw news that GE is acquiring the operations of a wind farm (http://bit.ly/1BIundJ) which seems more likely a foreclosure on a money-losing business. Still long GE but nervous.
    Mar 31, 2015. 12:40 PM | Likes Like |Link to Comment
  • Finger Lickin' Value Down At Sanderson Farms [View article]
    I have a question I can't seem to get answered. Why do some analysts forecast a 30-50% decline in earnings for 2016? I see the mean forecast earnings decline from $11.38/share in 2015 to $7.40/share in 2016. Is that because of surplus chicken supplies or some regulatory change, or related to avian flu and possible loss of some percentage of their chicken inventory?
    Mar 31, 2015. 12:16 PM | Likes Like |Link to Comment
  • Bristol-Myers Is Playing Chess, Gilead And AbbVie Are Playing Checkers [View article]
    SE, you picked a good title to draw readers, but I think GILD and ABBV are also playing chess with each other, just on a separate chess board. These are all smart companies here, after all.
    Mar 25, 2015. 04:36 PM | Likes Like |Link to Comment
  • JPMorgan: A Premium Firm At A Standard Price [View article]
    Is it possible that WFC has a higher quality loan portfolio (and thus lower risk) than JPM? Is there any way to aggregate the book value of the assets that collateralize their loans? That may explain the difference.
    Mar 18, 2015. 01:27 PM | Likes Like |Link to Comment
  • Report: DOJ wants $1B each from banks over forex [View news story]
    Sad to say our government has become an extortion racket. But it's hard to deny; the banks are a soft rich target.
    Mar 13, 2015. 08:06 PM | 2 Likes Like |Link to Comment
  • Why You Should Buy Magna International In This Current Price Dip [View article]
    Thanks for the article. I'm long MGA but concerned about the collapse in Euro purchasing power and overall macro effects coming on the back of the strong dollar. I think the market is discounting this already and just waiting for lower earnings to reflect this slowdown. Hopefully the central bankers will let the market know soon that they see this coming too.
    Mar 13, 2015. 06:31 PM | Likes Like |Link to Comment
  • Why Qualcomm Stock Is A Buy Right Now [View article]
    I guess any value investor should look at the valuations and answer the question, why is the valuation so low? I see China mentioned here, but just saw another article that said something like 98% of QCOM revenues come from outside the US and could decline significantly due to strong dollar. Comments?
    Mar 12, 2015. 12:00 PM | 1 Like Like |Link to Comment
  • $10 version of Sovaldi available in Bangladesh [View news story]
    Thinking about this from a public policy standpoint, there seems to be an "eminent domain" concept involved here. Perhaps the providers and payers (government and private) could agree on a discounted present value of the HCV market as a whole and divvy out cash to reward and compensate the innovators, then just price the drugs closer to production costs via some sort of public/private consortium. Hopefully some solution could be found that would both serve public health and provide good incentives for this type of innovation in the future. Leaving it to the "free market wolves" may not lead to the best outcome in this case. BTW I am still nervously long GILD.
    Mar 10, 2015. 11:55 AM | Likes Like |Link to Comment
  • $10 version of Sovaldi available in Bangladesh [View news story]
    Ptatty, well said! Clarity is always required, especially when the stock price doesn't behave the way the true believers wish.
    Mar 10, 2015. 10:30 AM | 1 Like Like |Link to Comment
  • $10 version of Sovaldi available in Bangladesh [View news story]
    X = Trust?
    Mar 9, 2015. 02:41 PM | 2 Likes Like |Link to Comment
  • $10 version of Sovaldi available in Bangladesh [View news story]
    Derrick, actually it's not poor people in the developed world but people who choose not to have health insurance and instead shop around the world for low cost care. Compared to $84,000 a hotel room and plane ticket is pretty cheap. I guess you aren't familiar with that trend. Also black markets for pharmaceuticals do actually exist and are quite robust.
    Mar 9, 2015. 12:07 PM | 4 Likes Like |Link to Comment
  • $10 version of Sovaldi available in Bangladesh [View news story]
    Hello black markets and pharma-tourism! This is an example of why people are increasingly shopping for healthcare in third world countries. Having such a wide disparity in prices and policies is an invitation to that sort of thing. I don't know how to solve this, but it sure will discourage medical innovation in the long run, especially if the solution is lowering the standards of the modern world.
    Mar 9, 2015. 11:30 AM | 1 Like Like |Link to Comment
  • JPMorgan's fund performance numbers are hard to recreate [View news story]
    That 100% number reminds me of the last election of Saddam Hussein.
    Mar 5, 2015. 10:30 AM | Likes Like |Link to Comment
  • AT&T To Face Disruption From Google's Entry Into Wireless [View article]
    I hate to use anecdotal evidence, but when I saw my 87-year-old mother's AT&T bill and see she is still being charged for "long distance", I realized how old-school this company really is. Old-school tech companies are always battling declining cash cows that are being starved in favor of cap-ex to compete with daunting new technologies from upstarts. Old-tech managers survive via financial engineering until they either get lucky with an acquisition or get killed. I cut my T position in half recently.
    Mar 3, 2015. 06:54 PM | Likes Like |Link to Comment
COMMENTS STATS
104 Comments
154 Likes